BCK Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$695K Sell
2,737
-70
-2% -$16.3K 0.34% 13
2026
Q1
$686K Hold
2,807
0.37% 13
2025
Q4
$581K Hold
2,807
0.31% 15
2025
Q3
$520K Hold
2,807
0.28% 15
2025
Q2
$429K Hold
2,807
0.25% 16
2025
Q1
$466K Sell
2,807
-225
-7% -$35.2K 0.29% 16
2024
Q4
$438K Sell
3,032
-460
-13% -$71.3K 0.27% 17
2024
Q3
$566K Sell
3,492
-37
-1% -$5.89K 0.27% 18
2024
Q2
$516K Sell
3,529
-234
-6% -$34.8K 0.27% 18
2024
Q1
$595K Buy
3,763
+262
+7% +$41.7K 0.32% 16
2023
Q4
$549K Hold
3,501
0.31% 17
2023
Q3
$545K Buy
3,501
+377
+12% +$62.2K 0.34% 18
2023
Q2
$517K Sell
3,124
-520
-14% -$83.9K 0.32% 17
2023
Q1
$565K Hold
3,644
0.37% 17
2022
Q4
$644K Sell
3,644
-379
-9% -$65.4K 0.44% 16
2022
Q3
$657K Buy
4,023
+16
+0.4% +$2.71K 0.48% 17
2022
Q2
$711K Sell
4,007
-30
-0.7% -$5.34K 0.5% 12
2022
Q1
$715K Hold
4,037
0.44% 13
2021
Q4
$691K Sell
4,037
-13
-0.3% -$2.13K 0.41% 13
2021
Q3
$654K Hold
4,050
0.42% 13
2021
Q2
$667K Hold
4,050
0.44% 13
2021
Q1
$675K Sell
4,050
-150
-4% -$24.3K 0.48% 13
2020
Q4
$661K Buy
+4,200
New +$620K 0.58% 12

Other funds holding JNJ

BCK Partners's JNJ Position: Q2 2026 in Review

BCK Partners reduced its Johnson & Johnson (JNJ) stake by 2.5% in Q2 2026, selling an estimated $16.3K and leaving 2,737 shares worth $695K. The position accounts for 0.34% of the portfolio, ranked #13.

BCK Partners first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. The position peaked at $715K in Q1 2022. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BCK Partners held 2,737 shares of Johnson & Johnson worth $695K as of Q2 2026.
  • BCK Partners sold 70 Johnson & Johnson shares in Q2 2026, an estimated $16.3K.
  • Johnson & Johnson made up 0.34% of BCK Partners's portfolio in Q2 2026, its #13 holding.
  • BCK Partners first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
  • BCK Partners's Johnson & Johnson position peaked at $715K in Q1 2022.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BCK Partners's 13F filing for Q2 2026, filed 20 Jul 2026.